| | | | | |
PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated | $9,1500 | +0,00% | $118,87M | $11,86K | |
PLYX Polaryx Therapeutics, Inc. Common Stock | $2,1900 | +0,00% | $118,83M | $822,00 | |
PGAC Pantages Capital Acquisition Corporation Class A Ordinary Shares | $10,5400 | -1,31% | $118,41M | $10,00 | |
DMO Western Asset Mortgage Opportunity Fund Inc. | $10,3900 | +0,00% | $118,27M | $35,38K | |
ENGN enGene Therapeutics Inc. Common Stock | $1,7900 | +1,13% | $117,90M | $20,00 | |
ANIX Anixa Biosciences, Inc. | $3,4400 | +0,88% | $117,71M | $8,000 | |
OPRX OptimizeRx Corporation Common Stock | $6,5700 | +0,31% | $117,65M | $1,000 | |
| $1,0100 | -0,98% | $117,55M | $110,00 | |
JELD JELD-WEN Holding, Inc. | $1,6200 | +12,50% | $117,16M | $63,56K | |
MCN XAI Madison Equity Premium Income Fund | $5,6400 | +0,00% | $117,14M | $77,93K | |
WSBK Winchester Bancorp, Inc. Common Stock | $13,0200 | -0,15% | $117,11M | $4,39K | |
NEOV NeoVolta Inc. Common Stock | $2,4650 | -0,20% | $116,95M | $2,08K | |
BRKH Burtech Acquisition Corp II Class A Ordinary Shares | $9,9500 | +0,10% | $116,90M | $12,22K | |
| $8,1100 | +0,00% | $116,86M | $27,02K | |
MBOT Microbot Medical, Inc. Common Stock | $1,7650 | -0,28% | $116,86M | $5,07K | |
